Updates are available Correction dated 2025-05-09
Click to view Correction: https://doi.org/10.1007/s41030-025-00298-y
-
Authors
Cheng, Mickie H.
Mann, Alex J.
Maas, Brian M.
Zhao, Tian
Bevan, Melissa
Schaeffer, Andrea K.
Liao, Laura E.
Catchpole, Andrew P.
Hilbert, David W.
Aubrey Stoch, S.
De Anda, Carisa S.
-
Funding
Funding for this research was provided by:
Merck (Funding for this research was provided by Merck Sharp)
Merck (Dohme LLC)
Merck (a subsidiary of Merck)
Merck (Co.)
Merck (Inc.)
Merck (Rahway)
Merck (NJ)
Merck (USA.)
- License Information
-
More Information
Article History
Received: 15 November 2024
Accepted: 10 February 2025
First Online: 2 April 2025
Change Date: 23 April 2025
Change Type: Update
Change Details: The original online version of this article was revised: the Clinical Trial Registration Number has been corrected from ‘NCT0555005’ to ‘NCT05559905’
Change Date: 9 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s41030-025-00298-y
Declarations
:
: Mickie Cheng, Brian M. Maas, Tian Zhao, Andrea K. Schaeffer, Laura E. Liao, S. Aubrey Stoch, and Carisa S. De Anda are employees of the trial sponsor Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD), who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA. Alex Mann, Melissa Bevan, and Andrew Catchpole are employees of hVIVO, which contracted with the trial sponsor to conduct this clinical trial.
: The study was conducted in accordance with principles of Good Clinical Practice (in accordance with the ethical principles that have their origin in the Declaration of Helsinki) and was approved by the appropriate institutional review board (South Central - Berkshire B Research Ethics Committee; REC reference 22/SC/0314) and all appropriate regulatory agencies. Written informed consent was obtained from all participants prior to their participation in the trial.
